ArticleFrontiers in immunology2026
The mechanism regulating the cytotoxicity of γδ T cells activated by mycobacterium tuberculosis heat-resistant antigen based on RNA-seq analysis.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Vγ9Vδ2 T cells in tuberculosis: protective immunity and translational perspectives.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a major global health threat. γδ T cells, critical innate immune responders, provide rapid anti-TB defenses and act as a bridge between innate and adaptive immunity. Studies have demonstrated that γδ T-cell activation by phosphoantigens is mediated by butyrophilin subfamily 3 member A1 (BTN3A1), leading to enhanced cytokine production and cytotoxicity. Mtb heat-resistant antigen (Mtb-HAg), extracted from Mtb H37Ra, specifically activates γδ T cells and induces cytokine secretion. However, the contribution of Mtb-HAg to γδ T cell-mediated cytotoxicity and its dependence on BTN3A1 remain unclear. Methods: This study explored the regulatory mechanism of Mtb-HAg on the cytotoxic function of γδ T cells through RNA-Seq analysis and functional validation methods. The RNA-Seq analysis to profile the transcriptome of Mtb-HAg-activated γδ T cells.The expression of key cytotoxic factors was analyzed using ELISA, and the capacity of activated γδ T cells to inhibit intracellular Mtb growth was assessed using a co-culture assay with Mtb-infected macrophages. The specific role of BTN3A1 was investigated using a blocking antibody to assess its impact on activation markers, cytotoxic factor secretion, and mycobacterial killing efficiency. Results: RNA-Seq analysis revealed that Mtb-HAg-activated γδ T cells are significantly enriched for genes associated with cytotoxic immune responses, with significant upregulation of key cytotoxic factors granzyme B (GzmB) and perforin (PFP), indicating that the cytotoxic function of these cells was activated at the transcriptional level. Subsequently, protein expression analysis revealed that the secretion of GzmB and PFP was increased in Mtb-HAg-activated γδ T cells. Meanwhile, intracellular Mtb growth inhibition assays demonstrated that activated γδ T cells lysed infected target cells and suppressed intracellular Mtb proliferation. We further found that BTN3A1 blockade significantly reduced the expression of CD69 and CD107a in γδ T cells, decreased the secretion of GzmB and PFP, and diminished the killing efficiency of γδ T cells against Mtb-infected macrophages. Conclusion: Our findings demonstrated that Mtb-HAg enhances the cytolytic activity of γδ T cells and inhibits intracellular Mtb growth, with BTN3A1 playing a regulatory role in these processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.